INEGY 10 MG80 MG TABLETS

国家: 以色列

语言: 英文

来源: Ministry of Health

有效成分:

EZETIMIBE; SIMVASTATIN

可用日期:

MERCK SHARP & DOHME ISRAEL LTD

ATC代码:

C10AA01

药物剂型:

TABLETS

组成:

SIMVASTATIN 80 MG; EZETIMIBE 10 MG

给药途径:

PER OS

处方类型:

Required

厂商:

MERCK SHARP & DOHME B.V., THE NETHERLANDS

治疗组:

SIMVASTATIN

治疗领域:

SIMVASTATIN

疗效迹象:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH. Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

授权日期:

2012-04-30